Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
60 Degrees Pharmaceuticals Inc. (SXTP) had Consolidated Net Income/Loss of $-2.27M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.21M |
|
$-2.26M |
|
$0.15M |
|
$0.06M |
|
$2.48M |
|
$-2.27M |
|
$0.01M |
|
$-2.27M |
|
$-2.27M |
|
$-2.27M |
|
$-2.27M |
|
|
Consolidated Net Income/Loss |
$-2.27M |
$-2.27M |
|
$-2.27M |
|
$-2.19M |
|
2.65M |
|
2.65M |
|
$-0.90 |
|
$-0.90 |
|
| Balance Sheet Financials | |
$3.73M |
|
$0.24M |
|
$0.55M |
|
$4.28M |
|
$1.61M |
|
-- |
|
$0.15M |
|
$1.75M |
|
$-7.04M |
|
$2.22M |
|
$2.53M |
|
2.66M |
|
| Cash Flow Statement Financials | |
$-4.97M |
|
$1.11M |
|
$3.37M |
|
$1.51M |
|
$1.02M |
|
$-0.49M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
27.32% |
|
-1092.41% |
|
-1092.41% |
|
-- |
|
-1089.76% |
|
-1089.25% |
|
$-5.04M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.17 |
|
0.37 |
|
245.47 |
|
32.19% |
|
-102.07% |
|
-52.90% |
|
-89.60% |
|
$0.95 |
|
$-1.90 |
|
$-1.87 |
|